Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities
Sarah J. Tabrizi(Huntington's Disease Association), Carlos Estevez‐Fraga(National Hospital for Neurology and Neurosurgery), Willeke van Roon‐Mom(Leiden University Medical Center), Michael Flower(National Hospital for Neurology and Neurosurgery), Rachael I. Scahill(National Hospital for Neurology and Neurosurgery), Edward J. Wild(Huntington's Disease Association), Ignacio Muñoz-Sanjuán(CHDI Foundation), Cristina Sampaio(CHDI Foundation), Anne Rosser(Cardiff University), Blair R. Leavitt(University of British Columbia)
Cited by 315Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis